secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001628280-25-009490
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals gets second Nasdaq compliance period until Aug 11, 2025 for bid price rule
--------------------------------------------------------------------------------

- Closing bid price of XFOR common stock below $1 for 32 consecutive business days as of Aug 13, 2024.
- Initial 180-day compliance period ended Feb 10, 2025; Nasdaq granted additional 180 days to Aug 11, 2025.
- Company may effect a reverse stock split to regain compliance if necessary.
- Failure to comply by Aug 11, 2025 may lead to delisting and an appeal process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025009490/0001628280-25-009490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025009490/xfor-20250303.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-009490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer